Regulation mechanism of ABCA1 expression by statins in hepatocytes

European Journal of Pharmacology

Volumn 662, Issue 1-3, 2011, Pages 9-14

  Kobayashi, Masaki ^a   Gouda, Keisuke ^a   Chisaki, Ikumi ^a   Ochiai, Manami ^a   Itagaki, Shirou ^a,b   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

ABCA1; Hepatocyte; PPARs; Regulation; Statin

Indexed keywords

ABC TRANSPORTER A1; ATORVASTATIN; CLOFIBRATE; GW 6471; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PITAVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG BINDING SITE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HEPTANOIC ACIDS; HUMANS; MALE; PPAR ALPHA; PYRROLES; QUINOLINES; RATS; RATS, WISTAR;

EID: 79957606434     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.04.043     Document Type: Article

References (22)

1. Aiello, R.J., Brees, D., Francone, O.L., 2003. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 23, 972-980.
2. Argmann, C.A., Edwards, J.Y., Sawyez, C.G., O'Neil, C.H., Hegele, R.A., Pickering, J.G., Huff, M.W., 2005. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J. Biol. Chem. 280, 22212-22221.
3. Chawla, A., Boisvert, W.A., Lee, C.H., Laffitte, B.A., Barak, Y., Joseph, S.B., Liao, D., Nagy, L., Edwards, P.A., Curtiss, L.K., Evans, R.M., Tontonoz, P., 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7, 161-171. (Pubitemid 32162909)
4. Chinetti, G., Fruchart, J.C., Staels, B., 2006. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR. Biochem. Soc. Trans. 34, 1128-1131.
5. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., Wahli, W., 1992. Control of the peroxisomal-oxidation pathway by a novel family of nuclear hormone receptor. Cell 68, 879-887.
6. Goldstein, J.L., Brown, M.S., 1990. Regulation of the mevalonate pathway. Nature (Lond.) 343, 425-430.
7. Havel, R.J., Rapaport, E., 1995. Management of primary hyperlipidemia. N. Engl. J. Med. 332, 1491-1498.
8. Johnson, B.M., Zhang, P., Schuetz, J.D., Brouwer, K.L., 2006. Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab. Dispos. 34, 556-562.
9. Kobayashi, M., Chisaki, I., Narumi, K., Hidaka, K., Kagawa, T., Itagaki, S., Hirano, T., Iseki, K., 2008a. Association between risk of myopathy and cholesterol-lowering effect: a comparison of all statins. Life Sci. 82, 969-975.
10. Kobayashi, M., Fujita, I., Itagaki, S., Hirano, T., Iseki, K., 2005. Transport mechanismfor L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD cells). Biol. Pharm. Bull. 28, 1197-1201.
11. Kobayashi, M., Kagawa, T., Narumi, K., Itagaki, S., Hirano, T., Iseki, K., 2008b. Bicarbonate supplementation as a preventive way in statins-induced muscle damage. J. Pharm. Pharm. Sci. 11, 1-8.
12. Kobayashi, M., Otsuka, Y., Itagaki, S., Hirano, T., Iseki, K., 2006. Inhibitory effects of statins on human monocarboxylate transporter 4. Int. J. Pharm. 317, 19-25.
13. Lee, J.Y., Parks, J.S., 2005. ATP-binding cassette transporter AI and its role in HDL formation. Curr. Opin. Lipidol. 16, 19-25.
14. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
15. Miyazaki, M., Mars, W.M., Runge, D., Kim, T.H., Bowen, W.C., Michalopoulos, G.K., 1998. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor. Exp. Cell Res. 241, 445-457.
16. Ogata, M., Tsujita, M., Hossain, M.A., Akita, N., Gonzalez, F.J., Staels, B., Suzuki, S., Fukutomi, T., Kimura, G., Yokoyama, S., 2009. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 205, 413-419.
17. Seo, M., Inoue, I., Ikeda, M., Nakano, T., Takahashi, S., Katayama, S., Komoda, T., 2008. Statins Activate Human PPARalpha Promoter and Increase PPARalpha mRNA Expression and Activation in HepG2 Cells. PPAR Res. 316306.
18. Tamehiro, N., Shigemoto-Mogami, Y., Kakeya, T., Okuhira, K., Suzuki, K., Sato, R., Nagao, T., Nishimaki-Mogami, T., 2007. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J. Biol. Chem. 282, 21090-21099.
19. Torra, I.P., Chinetti, G., Duval, C., Fruchart, J.C., Staels, B., 2001. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Curr. Opin. Lipidol. 12, 245-254.
20. Wellington, C.L., Brunham, L.R., Zhou, S., Singaraja, R.R., Visscher, H., Gelfer, A., Ross, C., James, E., Liu, G., Huber, M.T., Yang, Y.Z., Parks, R.J., Groen, A., Fruchart-Najib, J., Hayden, M.R., 2003. Alterations of plasma lipids in mice via adenoviral mediated hepatic overexpression of human ABCA1. J. Lipid Res. 44, 1470-1480. (Pubitemid 37279591)
21. Wong, J., Quinn, C.M., Brown, A.J., 2004. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux. Arterioscler. Thromb. Vasc. Biol. 24, 2365-2371.
22. Yokote, K., Bujo, H., Hanaoka, H., Shinomiya, M., Mikami, K., Miyashita, Y., Nishikawa, T., Kodama, T., Tada, N., Saito, Y., 2008. Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). Atherosclerosis 201, 345-352.